460 related articles for article (PubMed ID: 30832722)
1. Effects of vitamin D supplementation on liver fibrogenic factors in non-alcoholic fatty liver patients with steatohepatitis: study protocol for a randomized clinical trial.
Ebrahimpour-Koujan S; Sohrabpour AA; Foroughi F; Alvandi E; Esmaillzadeh A
Trials; 2019 Mar; 20(1):153. PubMed ID: 30832722
[TBL] [Abstract][Full Text] [Related]
2. Effects of vitamin D supplementation on liver fibrogenic factors, vitamin D receptor and liver fibrogenic microRNAs in metabolic dysfunction-associated steatotic liver disease (MASLD) patients: an exploratory randomized clinical trial.
Ebrahimpour-Koujan S; Sohrabpour AA; Giovannucci E; Vatannejad A; Esmaillzadeh A
Nutr J; 2024 Feb; 23(1):24. PubMed ID: 38413933
[TBL] [Abstract][Full Text] [Related]
3. The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M; Keshavarz SA; Mansouri S; Qorbani M; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
Trials; 2017 Jun; 18(1):260. PubMed ID: 28592311
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D supplementation for the treatment of non-alcoholic fatty liver disease: A randomized double blind placebo controlled trial.
Dabbaghmanesh MH; Danafar F; Eshraghian A; Omrani GR
Diabetes Metab Syndr; 2018 Jul; 12(4):513-517. PubMed ID: 29588137
[TBL] [Abstract][Full Text] [Related]
5. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
[TBL] [Abstract][Full Text] [Related]
6. The effect of daily consumption of probiotic yogurt on liver enzymes, steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized clinical trial.
Ebrahimi-Mousavi S; Alavian SM; Sohrabpour AA; Dashti F; Djafarian K; Esmaillzadeh A
BMC Gastroenterol; 2022 Mar; 22(1):102. PubMed ID: 35255811
[TBL] [Abstract][Full Text] [Related]
7. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome.
Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483
[TBL] [Abstract][Full Text] [Related]
8. Regression of Non-Alcoholic Fatty Liver by Vitamin D Supplement: A Double-Blind Randomized Controlled Clinical Trial.
Lorvand Amiri H; Agah S; Mousavi SN; Hosseini AF; Shidfar F
Arch Iran Med; 2016 Sep; 19(9):631-8. PubMed ID: 27631178
[TBL] [Abstract][Full Text] [Related]
9. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled clinical trial comparing calcitriol versus cholecalciferol supplementation to reduce insulin resistance in patients with non-alcoholic fatty liver disease.
Mahmoudi L; Asadi S; Al-Mousavi Z; Niknam R
Clin Nutr; 2021 May; 40(5):2999-3005. PubMed ID: 33341312
[TBL] [Abstract][Full Text] [Related]
11. Effect of a high-protein diet with β-cryptoxanthin supplementation on metabolic risk factors, oxidative and inflammatory biomarkers in non-alcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled clinical trial.
Haidari F; Hojhabrimanesh A; Helli B; Seyedian SS; Ahmadi-Angali K
Trials; 2018 Nov; 19(1):634. PubMed ID: 30445988
[TBL] [Abstract][Full Text] [Related]
12. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
[TBL] [Abstract][Full Text] [Related]
13. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
Daneshi-Maskooni M; Keshavarz SA; Qorbani M; Mansouri S; Alavian SM; Badri-Fariman M; Jazayeri-Tehrani SA; Sotoudeh G
BMC Complement Altern Med; 2019 Mar; 19(1):59. PubMed ID: 30871514
[TBL] [Abstract][Full Text] [Related]
14. The effect of co supplementation of omega-3 and vitamin D on cardio metabolic risk factors and psychological distress in reproductive-aged women with prediabetes and hypovitaminosis D: a study protocol for a randomized controlled trial.
Rajabi-Naeeni M; Dolatian M; Qorbani M; Vaezi AA
Trials; 2019 Dec; 20(1):799. PubMed ID: 31888762
[TBL] [Abstract][Full Text] [Related]
15. Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial.
Barroso LN; Salarini J; Leite NC; Villela-Nogueira CA; Dávalos A; Carmo MDGT; Ferreira Peres WA
Clin Nutr ESPEN; 2023 Oct; 57():117-125. PubMed ID: 37739645
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials.
Guo XF; Wang C; Yang T; Li S; Li KL; Li D
Food Funct; 2020 Sep; 11(9):7389-7399. PubMed ID: 32966467
[TBL] [Abstract][Full Text] [Related]
17. Effect of vitamin D supplementation on various parameters in non-alcoholic fatty liver disease patients.
Hussain M; Iqbal J; Malik SA; Waheed A; Shabnum S; Akhtar L; Saeed H
Pak J Pharm Sci; 2019 May; 32(3 Special):1343-1348. PubMed ID: 31551213
[TBL] [Abstract][Full Text] [Related]
18. Glucose homeostasis, insulin resistance and inflammatory biomarkers in patients with non-alcoholic fatty liver disease: Beneficial effects of supplementation with microalgae Chlorella vulgaris: A double-blind placebo-controlled randomized clinical trial.
Ebrahimi-Mameghani M; Sadeghi Z; Abbasalizad Farhangi M; Vaghef-Mehrabany E; Aliashrafi S
Clin Nutr; 2017 Aug; 36(4):1001-1006. PubMed ID: 27475283
[TBL] [Abstract][Full Text] [Related]
19. The effects of grape seed extract supplementation on cardiovascular risk factors, liver enzymes and hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
Ghanbari P; Raiesi D; Alboebadi R; Zarejavid A; Dianati M; Razmi H; Bazyar H
BMC Complement Med Ther; 2024 May; 24(1):192. PubMed ID: 38755622
[TBL] [Abstract][Full Text] [Related]
20. Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial.
Della Corte C; Carpino G; De Vito R; De Stefanis C; Alisi A; Cianfarani S; Overi D; Mosca A; Stronati L; Cucchiara S; Raponi M; Gaudio E; Byrne CD; Nobili V
PLoS One; 2016; 11(12):e0168216. PubMed ID: 27977757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]